The cancer diagnostics market is estimated to be valued at US$ 59.1 Billion in 2022 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Cancer diagnostics involves detection of biological markers present in tissues, blood or other body fluids that are indicative of cancer. Some of...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian